🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ELV
Enliven Therapeutics Inc
AVG HISTORICAL GAP
+0.53%
MAX GAP RECORD
+4.28%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ELVN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ELVN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (UNDETERMINED) | 🔮 UPCOMING 🔒 |
| Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE) |
+1.07%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+0.11%
|
| Mar 03, 2026 Earnings Release 2026-03-03 (AFTER CLOSE) |
-0.56%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
+0.05%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
-0.23%
|
| May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE) |
-2.26%
|
| Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE) |
+3.99%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.7%
Bullish Gaps (5)
Bearish Gaps (3)
Neutral / Flat (6)
📖 Intelligence Summary
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗